These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 21054888)

  • 41. Oridonin up-regulates expression of P21 and induces autophagy and apoptosis in human prostate cancer cells.
    Li X; Li X; Wang J; Ye Z; Li JC
    Int J Biol Sci; 2012; 8(6):901-12. PubMed ID: 22745580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer.
    Chen K; Ye J; Qi L; Liao Y; Li R; Song S; Zhou C; Feng R; Zhai W
    Anticancer Drugs; 2019 Oct; 30(9):925-932. PubMed ID: 31517732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
    Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
    Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression.
    Shi C; Yang EJ; Liu Y; Mou PK; Ren G; Shim JS
    Oncogene; 2021 Feb; 40(5):937-950. PubMed ID: 33293694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oridonin induces apoptosis through the mitochondrial pathway in human gastric cancer SGC-7901 cells.
    Gao S; Tan H; Zhu N; Gao H; Lv C; Gang J; Ji Y
    Int J Oncol; 2016 Jun; 48(6):2453-60. PubMed ID: 27082253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The transcription factor ZBP-89 suppresses p16 expression through a histone modification mechanism to affect cell senescence.
    Feng Y; Wang X; Xu L; Pan H; Zhu S; Liang Q; Huang B; Lu J
    FEBS J; 2009 Aug; 276(15):4197-206. PubMed ID: 19583777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways.
    Che X; Zhan J; Zhao F; Zhong Z; Chen M; Han R; Wang Y
    Biomed Res Int; 2021; 2021():4340950. PubMed ID: 34285910
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway.
    Liu H; Qian C; Shen Z
    Tumour Biol; 2014 Sep; 35(9):9139-46. PubMed ID: 24916572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myc, Cdk2 and cellular senescence: Old players, new game.
    Campaner S; Doni M; Verrecchia A; Fagà G; Bianchi L; Amati B
    Cell Cycle; 2010 Sep; 9(18):3655-61. PubMed ID: 20818171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flexicaulin A, An
    Xia Y; Lam CS; Li W; Sarwar MS; Liu K; Lee KM; Zhang HJ; Tsang SW
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth inhibition effects of ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid on colorectal carcinoma cells and colon carcinoma-bearing mice.
    Ye H; Wu Q; Guo M; Wu K; Lv Y; Yu F; Liu Y; Gao X; Zhu Y; Cui L; Liang N; Yun T; Li L; Zheng X
    Mol Med Rep; 2016 Apr; 13(4):3525-32. PubMed ID: 26935771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of oridonin on proliferation of HT29 human colon carcinoma cell lines both in vitro and in vivo in mice.
    Zhu Y; Xie L; Chen G; Wang H; Zhang R
    Pharmazie; 2007 Jun; 62(6):439-44. PubMed ID: 17663191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells.
    Takai N; Desmond JC; Kumagai T; Gui D; Said JW; Whittaker S; Miyakawa I; Koeffler HP
    Clin Cancer Res; 2004 Feb; 10(3):1141-9. PubMed ID: 14871994
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A recombinant adenovirus expressing p7(Kip1) induces cell cycle arrest and apoptosis in human 786-0 renal carcinoma cells.
    Katner AL; Gootam P; Hoang QB; Gnarra JR; Rayford W
    J Urol; 2002 Aug; 168(2):766-73. PubMed ID: 12131366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long noncoding RNA SNHG6 regulates p21 expression via activation of the JNK pathway and regulation of EZH2 in gastric cancer cells.
    Li Y; Li D; Zhao M; Huang S; Zhang Q; Lin H; Wang W; Li K; Li Z; Huang W; Che Y; Huang C
    Life Sci; 2018 Sep; 208():295-304. PubMed ID: 30031062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells.
    Wang H; Ye Y; Chui JH; Zhu GY; Li YW; Fong DW; Yu ZL
    Oncol Rep; 2010 Sep; 24(3):647-51. PubMed ID: 20664969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
    Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
    BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
    Dong X; Liu F; Li M
    Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Folic acid and sodium butyrate prevent tumorigenesis in a mouse model of colorectal cancer.
    Lu R; Wang X; Sun DF; Tian XQ; Zhao SL; Chen YX; Fang JY
    Epigenetics; 2008 Nov; 3(6):330-5. PubMed ID: 19098451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oridonin induces Mdm2-p60 to promote p53-mediated apoptosis and cell cycle arrest in neuroblastoma.
    Zhu HQ; Zhang C; Guo ZY; Yang JM; Guo JH; Chen C; Yao QH; Liu F; Zhang QW; Gao FH
    Cancer Med; 2019 Sep; 8(11):5313-5326. PubMed ID: 31339234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.